Table 3.

Baseline predictors of PrEP persistence beyond 6 months, among women who persisted beyond 1 month

	N (%) or median (IQR)		Univariate		Multivariate
	PrEP persisters	PrEP non‐persisters	Relative risk (95% CI)	p‐value	Relative risk a (95% CI)	p‐value
N participants	128 (19.8%)	518 (80.2%)
Age (years)	21 (20–23)	21 (19–23)	1.05 (0.99–1.13)	0.123	1.01 (0.94–1.09)	0.729
Contraceptive use
None/condoms only	57 (17.5%)	268 (82.5%)	ref		ref
Oral	1 (44.4%)	15 (55.6%)	2.53 (1.56–4.12)	<0.001	1.84 (1.11–3.05)	0.018
Injectable	39 (21.7%)	141 (78.3%)	1.24 (0.86–1.78)	0.255	1.23 (0.86–1.74)	0.260
Implant	13 (14.1%)	79 (85.9%)	0.81 (0.46–1.41)	0.446	0.81 (0.46–1.41)	0.455
IUD/other	7 (31.8%)	15 (68.2%)	1.81 (0.94–3.49)	0.075	1.41 (0.74–2.68)	0.290
Condom use, past 3 months
None	26 (16.6%)	131 (83.4%)	ref		–	–
Sometimes	84 (20.9%)	318 (79.1%)	1.26 (0.85–1.88)	0.254
Always	18 (21.4%)	66 (78.6%)	1.29 (0.75–2.22)	0.349
Modified VOICE risk score a , b
0–4	33 (22.5%)	114 (77.6%)	ref		ref
5–6	57 (23.0%)	191 (77.0%)	1.02 (0.70–1.49)	0.903	1.04 (0.72–1.51)	0.818
7–8	38 (15.5%)	207 (84.5%)	0.69 (0.45–1.05)	0.084	0.82 (0.54–1.26)	0.369

^a Adjusted for site.

^b Maximum score on the modified VOICE risk score is 8.